Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CymaBay Therapeutics Inc.

    NASDAQ: CBAY · Real-Time Price · USD
    32.48
    0.01 (0.03%)
    At close: Mar 21, 2024, 9:00 PM

    CymaBay Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -105.37M -106M -90M
    Depreciation & Amortization
    		 681K 710K 688K
    Stock-Based Compensation
    		 15.23M 9.52M 10M
    Other Working Capital
    		 2.9M -895K 4.04M
    Other Non-Cash Items
    		 14.03M 14.03M 2.9M
    Deferred Income Tax
    		 -2.73M n/a 637K
    Change in Working Capital
    		 5.63M -2.34M 6.35M
    Operating Cash Flow
    		 -72.53M -84.08M -69.43M
    Capital Expenditures
    		 -445K -148K -87K
    Cash Acquisitions
    		 -7.86M -874K 637K
    Purchase of Investments
    		 -305.67M -174.98M -78.08M
    Sales Maturities Of Investments
    		 219.55M 129.14M 126.76M
    Other Investing Acitivies
    		 7.86M 874K -637K
    Investing Cash Flow
    		 -86.57M -45.98M 48.59M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 345.77M 24.55M 118.45M
    Financial Cash Flow
    		 345.77M 24.55M 118.45M
    Net Cash Flow
    		 186.24M -105.52M 97.61M
    Free Cash Flow
    		 -72.98M -84.23M -69.52M

    Add to Watchlist